Skip to main content

Day: March 29, 2023

Traction Uranium Hits 6 Metres of Radioactivity up to 1,254 cps (Downhole Survey) Near Surface in Overburden and 52 Metres of Elevated Radioactivity in Basement Rocks Covered with Athabasca Sandstone in Diamond Drill Hole #KLS23-007

Key Lake South diamond drill hole #KLS23-007 is approximately 1 km away from the “Black Soil” high grade uranium mineralization (assayed 0.93 wt.% U3O8, 1180 ppm Cobalt, 625 ppm Nickel) the Company discovered in Fall 2022*Figure 1. Downhole Gamma Ray SurveyCALGARY, Alberta, March 29, 2023 (GLOBE NEWSWIRE) — Traction Uranium Corp. (CSE: TRAC) (OTC: TRCTF) (FRA: Z1K) (the “Company” or “Traction”) is pleased to announce it has intersected a 6 metre zone (“Zone 1 Overburden Anomaly”) of significant radioactivity encountered at shallow and near surface depth, starting from 1.6 metres to 7.6 metres within the overburden, followed by a 52 metre zone (“Zone 2 Basement Anomaly”), starting from 31 metres to 83 metres of “elevated radioactivity” in basement rocks from diamond drill hole #KLS23-007 in downhole probing (see Figure 1) at...

Continue reading

Mainz Biomed Reports Positive Results from Feasibility Study Evaluating its Portfolio of Novel mRNA Biomarkers for Early Detection of Advanced Colorectal Adenomas

Mainz Biomed’s proprietary nucleic acid extraction and PCR process proved to be highly effective Two mRNA biomarkers found to be particularly valuable in detecting disease signals in advanced adenoma samples eAArly DETECT clinical trial evaluating these biomarkers with fresh samples reporting results mid-year 2023 Results of eAArly DETECT will inform possible inclusion in U.S. Pivotal Clinical Trial (ReconAAsense) assessing Company’s CRC detection test ReconAAsense represents an opportunity to achieve gold standard status for self-administered colorectal cancer (CRC) screeningBERKELEY, Calif. and MAINZ, Germany, March 29, 2023 (GLOBE NEWSWIRE) — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today results of an...

Continue reading

Medigene AG Reports Full-Year 2022 Financial Results and Provides Corporate Update

Continued progress in 2022 with corporate strategy update, end-to-end platform innovation, pipeline expansion, and acceleration of lead candidate development Partnering momentum continues with a $3 million milestone payment from 2seventy bio Strengthened leadership with key hires in Corporate Development & Strategy, Investor Relations & Corporate Communications and Clinical Research & Development Cash runway maintained through 4Q 2024 Company to host a conference call today, March 29, 2023, at 3 pm CET/ 9 am ETMartinsried/Munich, March 29, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early stage immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today reported financial results for the year ended December 31, 2022 and provided a corporate...

Continue reading

Borregaard ASA: Proxies for the Annual General Meeting 18 April 2023

In connection with Borregaard’s Annual General Meeting, Mr. Per A. Sørlie, President and CEO of Borregaard ASA, has been assigned voting rights based on proxies for 7,297,565 shares in Borregaard ASA. The proxies apply exclusively to the Annual General Meeting in Borregaard ASA on 18 April 2023. This means that Mr. Per A. Sørlie represents a total of 7,30 % of the outstanding shares in Borregaard ASA. Mr. Per A. Sørlie’s personal shareholding in Borregaard ASA is 164,810 shares. Borregaard ASASarpsborg, 29 March 2023 Contact:Lotte Kvinlaug, Investor Relations Officer, +47 922 86 909 This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.  

Continue reading

Press release Biocartis Group NV: Biocartis To Publish 2022 Annual Report on 11 April 2023

PRESS RELEASE – REGULATED INFORMATION 29 March 2023, 07:00 CEST Biocartis To Publish 2022 Annual Report on 11 April 2023 Mechelen, Belgium, 29 March 2023 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces that it will publish its 2022 annual report on 11 April 2023, which is later than the previously communicated publication date, because the audit of the consolidated financial statements is not finalized with respect to the accounting treatment and the presentation of the various recapitalization transactions that completed on 16 January 2023. Biocartis’ 2022 annual report will be published simultaneously with the invitation to its annual shareholders’ meeting that will be held on Friday 12 May 2023 at 2:00 p.m. CEST at the offices of...

Continue reading

EfTEN REAL ESTATE FUND AS NOTICE CALLING THE ANNUAL GENERAL MEETING OF SHAREHOLDERS

The Management Board of EfTEN Real Estate Fund AS (previous business name EfTEN Real Estate Fund III AS; registry code 12864036; seat Tallinn, A. Lauteri 5) calls an annual general meeting of shareholders on 20 April 2023 at 10:00. Venue of the general meeting: Swissôtel Tallinn Conference Center at Tallinn, Tornimäe 3. The registration of participants of the general meeting starts at 09:00 on 20 April 2023 at the venue of the meeting. The registration ends at 10:00. If possible, we request that all shareholders arrive in time considering the time required to register the participants of the meeting. The list of shareholders who shall be entitled to participate in the annual general meeting shall be fixed seven days prior to the date of the general meeting, i.e., on 13 April 2023 as at the end of the working day of the registrar of the...

Continue reading

MCH Group | Ad hoc announcement pursuant to Art. 53 LR | Year-end Closing 2022

MCH Group: Significantly improved figures on previous year The key figures for MCH Group’s 2022 annual results are significantly up on the previous year. MCH Group was able to increase both its sales and its EBITDA by over 60 % compared with the previous year; the net loss was reduced to CHF 9.3 million. Consolidated key figures at a glance (figures for 2021 in brackets)Operating income: CHF 394.1 million (CHF 243.3 million) EBITDA: CHF 14.0 million (CHF 8.5 million) Loss for the year: CHF -9.3 million (CHF -17.3 million) Equity: CHF 113.3 million / 25.5% (CHF 47.8 million / 11.8%) Cash and cash equivalents: CHF 151.9 million (CHF 113.7 million) Net debt: CHF 84.6 million (CHF 132.7 million)The first trimester of 2022 was still strongly marked by the continuing effects of the Covid 19 pandemic. MCH Group estimates that the negative...

Continue reading

Construction contract in Lithuania (wind farm foundations, electrical cables and roads)

On 28 March 2023 UAB Merko Statyba, part of AS Merko Ehitus group, and UAB Vėjas LT, part of E energija group, entered into the contract to perform the construction of foundations for 16 wind turbines, electrical cables and roads in a windfarm located in the Kelmė district, Lithuania. The contract value is approximately EUR 30 million, plus value added tax. The project is scheduled to be completed in the second quarter of 2025. UAB Merko Statyba (merko.lt) is Lithuanian construction company, which offers construction services in the fields of general construction and residential construction. Additional information: UAB Merko Statyba, Construction Director Mr. Jaanus Rästas, phone: +370 6875 0680. Urmas SomelarHead of FinanceAS Merko Ehitus+372 650 1250urmas.somelar@merko.ee AS Merko Ehitus (group.merko.ee) group companies develop real...

Continue reading

DNO Starts Shutdown of Kurdistan Oilfields as Pipeline Closure Continues

Oslo, 29 March 2023 – DNO ASA, the Norwegian oil and gas operator, today announced that it has started an orderly shutdown of its operated oil fields in the Kurdistan region of Iraq four days after it was instructed to temporarily cease deliveries to the Iraq-Turkey Pipeline destined for the Mediterranean port of Ceyhan following an arbitration ruling in favor of Iraq against Turkey for exporting Kurdish oil without Baghdad’s approval. DNO had diverted oil production to storage tanks, but capacity is limited, as previously announced. The Company’s prolific Tawke and Peshkabir fields averaged combined production of 107,000 barrels of oil per day in 2022, representing a quarter of Kurdistan’s total exports. Peshkabir production was halted last night and plans drawn up to conduct deferred maintenance. Tawke production shutdown has started...

Continue reading

Beter Bed Holding announces AGM

Today, Beter Bed Holding N.V. (BBH) – the Netherlands’ largest sleep specialist in retail, wholesale and B2B – has published the notice and agenda for its Annual General Meeting (AGM) to be held on Wednesday, 10 May 2023. During the AGM, BBH will look back on the results achieved over 2022, and update the shareholders on the current developments. The agenda for the AGM and the notice are available on the Company’s website www.beterbedholding.com. About Beter Bed HoldingBeter Bed Holding (BBH) is the Netherlands’ leading sleep specialist in retail, wholesale and B2B. Our mission is simple. We believe that the better we sleep, the happier, healthier and more productive we are. And we won’t rest until everyone gets the high-quality sleep they deserve. Listed on Euronext Amsterdam, BBH operates the successful retail brands Beter Bed, Beddenreus,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.